Re: Apabetalone for non diabetics or normal cholesterol?
in response to
by
posted on
Dec 10, 2019 11:23AM
RVX should know the path forward from the FDA, very soon. And then ensuing applications for “breakthrough” with the FDA/EMA/China?
That information will obviously set the course regarding time and expense.
Key pieces of information not only for RVX, but also potential partners/buyers.
Not sure exactly what constitutes material information “RPX world” but hopefully that type of information is disclosed forthwith, to ALL investors. It would certainly seem material to me if I were looking to invest in RVX, or remain long?!
I would also certainly think that information in those areas would greatly impact valuation, and timing, for potential buyer/partners. And we all know partners/buyers are highly likely to be required for advancement.
waiting